Analysts’ Top Healthcare Picks: AGN, TMO

By Austin Angelo

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allergan (NYSE: AGN), Thermo Fisher (NYSE: TMO) and K2M Group Holdings (NASDAQ: KTWO) with bullish sentiments.

Allergan (NYSE: AGN)

In a report issued on October 10, Tyler Van Buren from Cowen & Co. reiterated a Buy rating on Allergan (NYSE: AGN), with a price target of $400. The company’s shares closed yesterday at $206.61.

According to TipRanks.com, Buren is a 1-star analyst with an average return of -1.1% and a 72.0% success rate. Buren covers the Healthcare sector, focusing on stocks such as Alder Biopharmaceuticals, Impax Laboratories, and OHR Pharmaceutical.

Currently, the analyst consensus on Allergan is Moderate Buy and the average price target is $271.30, representing a 31.3% upside.

In a report issued on September 25, RBC Capital also assigned a Buy rating to the stock with a $277 price target.
Thermo Fisher (NYSE: TMO)

Cowen & Co. analyst Doug Schenkel reiterated a Buy rating on Thermo Fisher (NYSE: TMO) yesterday and set a price target of $220. The company’s shares closed yesterday at $193.46, close to its 52-week high of $194.30.

According to TipRanks.com, Schenkel is a 4-star analyst with an average return of 7.5% and a 67.7% success rate. Schenkel covers the Healthcare sector, focusing on stocks such as Becton Dickinson, Oxford Immunotec, and Myriad Genetics.

Currently, the analyst consensus on Thermo Fisher is Strong Buy and the average price target is $209.11, representing an 8.1% upside.

In a report issued on September 26, Goldman Sachs also initiated coverage with a Buy rating on the stock with a $225 price target.
K2M Group Holdings (NASDAQ: KTWO)

In a report issued on October 9, Josh Jennings from Cowen & Co. reiterated a Buy rating on K2M Group Holdings (NASDAQ: KTWO), with a price target of $22. The company’s shares closed yesterday at $18.76.

According to TipRanks.com, Jennings is a 2-star analyst with an average return of 0.0% and a 53.3% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Corindus Vascular Robotics, Boston Scientific Corp, and Zimmer Biomet Holdings.

Currently, the analyst consensus on K2M Group Holdings is Strong Buy and the average price target is $24.80, representing a 32.2% upside.

In a report issued on September 28, Piper Jaffray also reiterated a Buy rating on the stock with a $28 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.